Orbis Research has announced the addition of the “Global Personalized Medicines Market Size, Status and Forecast 2018-2025” to store by company, by country, and by application/type for the competitive landscape analysis.
The Global Personalized Medicines Market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Personalized Medicines development in United States, Europe and China.
In 2017, the global Personalized Medicines market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Growing healthcare expenditure levels triggering the need for an effective diagnostic procedure for cancer, growing prevalence of cancer and increasing usage of combination biomarkers for diagnostics are few factors expected to boost market growth.
Request a sample of this report @ http://orbisresearch.com/contacts/request-sample/2293745 .
The key players covered in this study
3G Biotech
Quest Diagnostics
Laboratory Corporation of America
Abbott
Agendia NV
Asuragen Inc
Becton Dickinson
CardioDx Inc.
Foundation Medicine
Qiagen
Siemens Healthcare
Amgen
Bristol-Myers Squibb
GE Healthcare
Pfizer
Sanofi
23andMe
Illumina
Market segment by Type, the product can be split into
PM Diagnostics
PM Therapeutics
Personalized Medical Care
Personalized Nutrition & Wellness
Market segment by Application, split into
Hospitals Pharmacies
Retail Pharmacies
Dietary Care Centers
Others
If enquiry before buying this report @ http://orbisresearch.com/contacts/enquiry-before-buying/2293745 .
The study objectives of this report are:
To analyze global Personalized Medicines status, future forecast, growth opportunity, key market and key players.
To present the Personalized Medicines development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
Major Points from Tables of Content:
Chapter One: Report Overview
Chapter Two: Global Growth Trends
Chapter Three: Market Share by Key Players
Chapter Four: Breakdown Data by Type and Application
Chapter Five: United States
Chapter Six: Europe
Chapter Seven: China
Chapter Eight: Japan
Chapter Nine: Southeast Asia
Chapter Ten: India
Chapter Eleven: Central & South America
Chapter Twelve: International Players Profiles
Chapter Thirteen: Market Forecast 2018-2025
Chapter Fourteen: Analyst's Viewpoints/Conclusions
Chapter Fifteen: Appendix
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas - 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: [email protected]